USH2A p.Ser1349Phe
c.4046C>T · rs145148501 · VCV1215648
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1133 | likely benign |
|---|---|---|
| REVEL | 0.153 | moderately benign-leaning |
| SaProt | — | not scored · why |
| ⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.4 | GERP -0.28, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 797 kb · p 0.00011 · regional, not allelic |
| Overall | ||
| CADD | 17.39 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.032% | 3,127 |
| Admixed American | 0.00167% | 60,022 |
| European (non-Finnish) | 0.0011% | 90,766 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- USH2A
- Protein
- p.Ser1349Phe
- Coding
- c.4046C>T
- MANE Select
- NM_206933
- dbSNP
- rs145148501
- Type
- single nucleotide variant
- Location
- chr1:216198350 (GRCh38)
- Gene constraint
- LOEUF 0.855 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Residue 1349
- the fibronectin type-iii 3 domain; a UniProt-annotated variant site (in)
Disease context
retinitis pigmentosa 39 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Usher syndrome type 2A
For Retinitis pigmentosa (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Mitochondrial inheritance
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- USH2A c.12295-3T>A Pathogenic ★★★ same condition
- USH2A c.8559-2A>G Pathogenic ★★★ same condition
- USH2A c.8682-9A>G Pathogenic ★★★ same condition
- USH2A p.Ala4740Asp Pathogenic ★★★ ⚠ same condition
- USH2A p.Arg3905Cys Pathogenic ★★★ ⚠ same condition
- USH2A p.Arg4192Cys Likely pathogenic ★★★ ⚠ same condition
- USH2A p.Asn346His Pathogenic ★★★ same condition
- USH2A p.Asn4292Asp Likely pathogenic ★★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ush2a-p-ser1349phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown